Crowdonomics
All companies

Nature's Miracle Holding Inc.

Public

Industrial & Manufacturing · Upland, CA

Estimated pre-money ⓘ
$643K
As of Feb 2025 · from Reg A Offering (2025) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$0
Across 1 round since 2025
Latest share price
$0.15
Reg A Offering (2025) offering price

Financials

FY2022–FY2025 · from SEC filings · hover any figure for its source
$18.6M
−$2.5M
2022
$8.9M
−$7.3M
2023
$1.6M
−$13.7M
2024
$1.7M
−$12.0M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 audited
FY2023 audited
FY2024 audited
FY2025 audited
Income statement
Revenue
$18,621,344
$8,932,751
$1,593,926
$1,742,360
Cost of goods sold
$16,952,201
$9,881,622
$12,066,778
$2,193,398
Gross margin
9%
-11%
-657%
-26%
Net income
-$2,461,125
-$7,338,171
-$13,653,340
-$11,986,754
Taxes paid
-$68,444
$218,358
$5,100
$1,700
Balance sheet
Cash
$45,500
$221,760
$420,131
$97,694
Accounts receivable
$3,555,332
$1,236,248
$1,829,044
$153,043
Total assets
$20,849,015
$14,200,421
$11,311,819
$20,410,686
Short-term debt
$110,810
$268,805
$2,668,604
$4,192,646
Long-term debt
$2,967,218
$5,979,939
$5,678,550
$5,402,186
Total liabilities
$20,231,569
$20,920,358
$25,650,969
$31,693,169
Other
Headcount
—
18
—
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$643K
est. pre-money
Reg A+ · Equity · Feb 2025

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Mar 31, 2026
ClassOutstandingVotes / shareShare of totalLast price
Common Stock308,306,016—100.0%—

Shares outstanding over timein today's share terms

308M154M0
Dec 2022Mar 2026
Common StockSplit / conversion

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg A+ · Equity · Feb 2025Withdrawnvia D. Boral Capital LLC.
Raised $0 / $10MEst. pre-money $642.7K

Team

7 people
Tie (James) Li
Chairman, Chief Executive Officer, and Director
Varto Levon Doudakian
Vice President
Wenbing Chris Wang
Chief Financial Officer
Zhiyi (Jonathan) Zhang
President and Director
Charles Jourdan Hausman
Independent Director
H. David Sherman
Independent Director
Jon M. Montgomery
Independent Director

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 10-QMay 27, 20260001213900-26-061507
    EDGAR
  • Form 10-KApr 15, 20260001213900-26-044157
    EDGAR
  • Form 10-Q/AApr 14, 20260001213900-26-043188
    EDGAR
  • Form 10-QNov 14, 20250001213900-25-110907
    EDGAR
  • Form 10-QAug 14, 20250001213900-25-076814
    EDGAR
  • Form 10-QMay 15, 20250001213900-25-044131
    EDGAR
  • Form 1-A-WMay 6, 20250001213900-25-040172
    EDGAR
  • Form 10-KApr 16, 20250001213900-25-032230
    EDGAR
Source: SEC EDGARCIK 0001947861DEShare price $0.15Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.